Suppression Of Early Pro-Inflammatory Senescent Signature Post-Radiotherapy Mitigates Chronic Bone Damage
Cancer treatments like radiation therapy are vital for saving lives, but they can sometimes lead to unwanted side effects, such as long-term bone damage. This happens because radiation can cause some cells in the bone to prematurely age and stop dividing, a process known as cellular senescence. These “aged” cells then release a harmful mix of inflammatory chemicals, often referred to as the senescence-associated secretory phenotype (SASP), which acts like a distress signal, causing inflammation and damage to healthy bone tissue. New research suggests that by targeting these inflammatory signals early on, we might be able to prevent this chronic bone deterioration. Scientists found that a specific type of drug, called a Janus kinase (JAK) inhibitor, which can block these inflammatory signals, was effective in reducing bone loss and improving bone health after radiation exposure. This approach not only helped to maintain stronger bones but also reduced the overall burden of these aging cells and improved the bone’s structure. This discovery highlights a promising new strategy to protect bone health in cancer survivors by intervening at a critical early stage.
Source: link to paper